These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32288570)

  • 1. Influenza, respiratory syncytial virus and SARS.
    Thompson C; Zambon M
    Medicine (Abingdon); 2009 Dec; 37(12):679-685. PubMed ID: 32288570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza and other emerging respiratory viruses.
    Zambon M
    Medicine (Abingdon); 2014 Jan; 42(1):45-51. PubMed ID: 32288576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza, respiratory syncytial virus and SARS.
    Zambon M
    Medicine (Abingdon); 2005 May; 33(5):130-134. PubMed ID: 32308534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections.
    Behzadi MA; Leyva-Grado VH
    Front Microbiol; 2019; 10():1327. PubMed ID: 31275265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT findings in viral lower respiratory tract infections caused by parainfluenza virus, influenza virus and respiratory syncytial virus.
    Kim MC; Kim MY; Lee HJ; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    Medicine (Baltimore); 2016 Jun; 95(26):e4003. PubMed ID: 27368011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical features of respiratory syncytial virus: lower respiratory tract infection after upper respiratory tract infection due to influenza virus.
    Nishimura N; Nishio H; Lee MJ; Uemura K
    Pediatr Int; 2005 Aug; 47(4):412-6. PubMed ID: 16091079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative
    Pulit-Penaloza JA; Pappas C; Belser JA; Sun X; Brock N; Zeng H; Tumpey TM; Maines TR
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30158292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oseltamivir-zanamivir combination therapy suppresses drug-resistant H1N1 influenza A viruses in the hollow fiber infection model (HFIM) system.
    Pires de Mello CP; Drusano GL; Adams JR; Shudt M; Kulawy R; Brown AN
    Eur J Pharm Sci; 2018 Jan; 111():443-449. PubMed ID: 29079337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
    J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
    Correia V; Santos LA; Gíria M; Almeida-Santos MM; Rebelo-de-Andrade H
    J Med Virol; 2015 Jan; 87(1):45-56. PubMed ID: 25042157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.
    Wu Y; Gao F; Qi J; Bi Y; Fu L; Mohan S; Chen Y; Li X; Pinto BM; Vavricka CJ; Tien P; Gao GF
    J Virol; 2016 Dec; 90(23):10693-10700. PubMed ID: 27654293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of anti-neuraminidase drugs application during and after an influenza pandemic].
    Breslav NV; Shevchenko ES; Abramov DD; Prilipov AG; Zhuravleva MM; Oskerko TA; Kolobukhina LV; Merkulova LN; Shchelkanov MIu; Burtseva EI; L'vov DK
    Vopr Virusol; 2013; 58(1):28-32. PubMed ID: 23785758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Information of the Center for Ecology and Epidemiology of Influenza, D. I. Ivanovsky Research Institute of Virology, Russian Academy of Medical Sciences, on the results of the 2009-2010 influenza and acute respiratory viral infection epidemic season (at week 40 of 2009 to week 22 of 2010) in the world and Russia].
    L'vov DK; Burtseva EI; Lavrishcheva VV
    Vopr Virusol; 2011; 56(1):44-9. PubMed ID: 21427956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza virus resistance to neuraminidase inhibitors.
    Samson M; Pizzorno A; Abed Y; Boivin G
    Antiviral Res; 2013 May; 98(2):174-85. PubMed ID: 23523943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.